Boston Scientific Corporation (BSX) Earnings History
Profitable35 years of earnings data (1991–2025) · Positive TTM net income
Loading earnings history...
Boston Scientific Corporation (BSX) Earnings Overview
As of June 22, 2026, Boston Scientific Corporation (BSX) reported trailing twelve-month net income of $2.89B, reflecting +55.2% year-over-year growth. The company earned $1.93 per diluted share over the past four quarters, with a net profit margin of 14.4%.
Looking at the long-term picture, BSX's historical earnings data spans multiple years. The company achieved its highest annual net income of $4.70B in fiscal 2019.
Boston Scientific Corporation maintains positive profitability with a gross margin of 69.0%, operating margin of 19.8%, and net margin of 14.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), EW ($1.07B net income, 17.7% margin), SYK ($3.25B net income, 12.9% margin), BSX has outperformed on profitability metrics. Compare BSX vs MDT →
BSX Earnings vs Peers
Earnings metrics vs comparable public companies
BSX Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.89B | +55.7% | $3.97B | $1.94 | 14.4% | 19.8% |
| 2024 | $1.85B | +16.4% | $2.63B | $1.25 | 11.1% | 15.7% |
| 2023 | $1.59B | +128.2% | $2.18B | $1.07 | 11.2% | 15.3% |
| 2022 | $698M | -32.9% | $1.82B | $0.45 | 5.5% | 14.4% |
| 2021 | $1.04B | +1368.3% | $1.92B | $0.69 | 8.7% | 16.2% |
| 2020 | -$82M | -101.7% | $601M | $-0.08 | -0.8% | 6.1% |
| 2019 | $4.70B | +181.3% | $1.71B | $3.33 | 43.8% | 15.9% |
| 2018 | $1.67B | +1506.7% | $1.74B | $1.19 | 17.0% | 17.7% |
| 2017 | $104M | -70.0% | $1.52B | $0.07 | 1.1% | 16.9% |
| 2016 | $347M | +245.2% | $1.24B | $0.25 | 4.1% | 14.7% |
| 2015 | -$239M | -100.8% | $790M | $-0.18 | -3.2% | 10.6% |
| 2014 | -$119M | +1.7% | $845M | $-0.09 | -1.6% | 11.4% |
| 2013 | -$121M | +97.0% | $871M | $-0.09 | -1.7% | 12.2% |
| 2012 | -$4.07B | -1022.4% | $994M | $-2.89 | -56.1% | 13.7% |
| 2011 | $441M | +141.4% | $1.12B | $0.29 | 5.8% | 14.7% |
| 2010 | -$1.06B | -3.9% | $1.07B | $-0.70 | -13.6% | 13.7% |
| 2009 | -$1.02B | +49.7% | $1.30B | $-0.68 | -12.5% | 15.9% |
| 2008 | -$2.04B | -311.3% | $1.29B | $-1.36 | -25.3% | 16.1% |
| 2007 | -$495M | +86.2% | $1.18B | $-0.33 | -5.9% | 14.1% |
| 2006 | -$3.58B | -669.6% | $1.24B | $-2.81 | -45.7% | 15.8% |
| 2005 | $628M | -40.9% | $2.02B | $0.75 | 10.0% | 32.2% |
| 2004 | $1.06B | +125.0% | $1.77B | $1.24 | 18.9% | 31.5% |
| 2003 | $472M | +26.5% | $697M | $0.56 | 13.6% | 20.1% |
| 2002 | $373M | +790.7% | $610M | $0.45 | 12.8% | 20.9% |
| 2001 | -$54M | -114.5% | $100M | $-0.07 | -2.0% | 3.7% |
| 2000 | $373M | +0.5% | $675M | $0.45 | 14.0% | 25.3% |
| 1999 | $371M | +240.3% | $725M | $0.45 | 13.1% | 25.5% |
| 1998 | -$264M | -289.8% | -$222M | $-0.34 | -11.8% | -10.0% |
| 1997 | $139M | -16.6% | $415M | $0.17 | 7.4% | 22.2% |
| 1996 | $167M | +1988.8% | $342M | $0.21 | 11.4% | 23.4% |
| 1995 | $8M | -90.0% | $285M | $0.01 | 0.7% | 25.7% |
| 1994 | $80M | +14.3% | $130M | $0.19 | 17.8% | 29.0% |
| 1993 | $70M | +23.1% | $109M | $0.18 | 18.3% | 28.6% |
| 1992 | $57M | +35.4% | $93M | $0.14 | 18.0% | 29.4% |
| 1991 | $42M | - | $71M | $0.11 | 18.2% | 30.7% |
Download Data
Export BSX earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into BSX consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
35+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BSX — Frequently Asked Questions
Quick answers to the most common questions about buying BSX stock.
What is BSX earnings per share (EPS)?
BSX trailing twelve-month (TTM) diluted EPS is $1.93, reflecting +55.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1991 to 2025 is available in the table on this page.
What is Boston Scientific Corporation's net income?
Boston Scientific Corporation (BSX) trailing twelve-month net income is $2.9B as of 2025. Earnings grew +55.2% year-over-year. Boston Scientific Corporation has been profitable for 5 consecutive years.
Is BSX profitable?
Yes, BSX is profitable with a TTM net income of $2.9B and a net profit margin of +14.4%. Boston Scientific Corporation has generated profits for 5 consecutive years.
What is BSX's earnings growth rate?
BSX compound annual EPS growth rates (CAGR): 1-Year: +55.2%, 3-Year: +63.3%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1991 to 2025.
What are BSX's profit margins?
Boston Scientific Corporation net profit margin is +14.4%, operating margin is +19.8%, and gross margin is +69.0%. Margins are within a typical range for the sector. Return on Equity is +12.4%.
Is BSX growing earnings?
Yes, BSX earnings are accelerating — EPS growth of +55.2% exceeds the 5-year CAGR of N/A. TTM net income reached $2.9B. Earnings momentum is strengthening.
What was BSX's best earnings year?
Boston Scientific Corporation's highest annual net income on record is $4.7B, achieved in fiscal year 2019. Earnings history on this page spans 1991 to 2025 and includes all annual and quarterly figures.
What were BSX's earnings last quarter?
BSX's most recent reported quarter was Q4 2025. Net income was $668M with diluted EPS of $0.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.